The regulatory approval in the EU comes approximately six months after Novocure secured FDA approval of the system.

Summit Therapeutics shares rallied after its lung cancer drug candidate showed that it improved patients' longevity without the disease worsening in a late-stage trial. Shares of Summit rose 11% to ...

To diagnose lung cancer and determine the optimal treatment strategy, physicians typically rely on tissue examination. However, taking biopsies is ...

Soha Ali Khan reveals Sharmila Tagore’s early-stage lung cancer battle Learn how early detection saved her life and the ...

“There are few treatment options for people living with this ... “The CE Mark approval for Optune Lua for metastatic non-small cell lung cancer is a significant milestone in Novocure’s ...

Optellum, a global leader in AI-driven clinical decision support for early lung cancer diagnosis, has entered an agreement ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.